{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "64764-800",
      "generic_name": "MARIBAVIR",
      "labeler_name": "Takeda Pharmaceuticals America, Inc.",
      "brand_name": "Livtencity",
      "active_ingredients": [
        {
          "name": "MARIBAVIR",
          "strength": "200 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "64764-800-28",
          "description": "1 BOTTLE in 1 CARTON (64764-800-28)  / 28 TABLET, COATED in 1 BOTTLE",
          "marketing_start_date": "20211123",
          "sample": false
        },
        {
          "package_ndc": "64764-800-56",
          "description": "1 BOTTLE in 1 CARTON (64764-800-56)  / 56 TABLET, COATED in 1 BOTTLE",
          "marketing_start_date": "20211123",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Takeda Pharmaceuticals America, Inc."
        ],
        "rxcui": [
          "2586073",
          "2586079"
        ],
        "spl_set_id": [
          "c94fc2c5-e840-4f18-b7d8-d5eacb26d3a0"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000193976",
          "N0000193977",
          "N0000182141",
          "N0000185503",
          "N0000190113"
        ],
        "pharm_class_epc": [
          "Cytomegalovirus pUL97 Kinase Inhibitor [EPC]"
        ],
        "pharm_class_moa": [
          "Cytomegalovirus pUL97 Kinase Inhibitors [MoA]",
          "Cytochrome P450 3A4 Inhibitors [MoA]",
          "P-Glycoprotein Inhibitors [MoA]",
          "Breast Cancer Resistance Protein Inhibitors [MoA]"
        ],
        "unii": [
          "PTB4X93HE1"
        ]
      },
      "marketing_category": "NDA",
      "dosage_form": "TABLET, COATED",
      "spl_id": "14acb19d-0258-47df-a01a-bdca1ea05e54",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20211123",
      "product_id": "64764-800_14acb19d-0258-47df-a01a-bdca1ea05e54",
      "application_number": "NDA215596",
      "brand_name_base": "Livtencity",
      "pharm_class": [
        "Breast Cancer Resistance Protein Inhibitors [MoA]",
        "Cytochrome P450 3A4 Inhibitors [MoA]",
        "Cytomegalovirus pUL97 Kinase Inhibitor [EPC]",
        "Cytomegalovirus pUL97 Kinase Inhibitors [MoA]",
        "P-Glycoprotein Inhibitors [MoA]"
      ]
    }
  ]
}